165 related articles for article (PubMed ID: 31908461)
1. Exploration of Treatment-Resistant Schizophrenia Subtypes Based on a Survey of 204 US Psychiatrists.
Correll CU; Brevig T; Brain C
Neuropsychiatr Dis Treat; 2019; 15():3461-3473. PubMed ID: 31908461
[TBL] [Abstract][Full Text] [Related]
2. Patient characteristics, burden and pharmacotherapy of treatment-resistant schizophrenia: results from a survey of 204 US psychiatrists.
Correll CU; Brevig T; Brain C
BMC Psychiatry; 2019 Nov; 19(1):362. PubMed ID: 31727015
[TBL] [Abstract][Full Text] [Related]
3. Caregiver Burdens Associated With Treatment-Resistant Schizophrenia: A Quantitative Caregiver Survey of Experiences, Attitudes, and Perceptions.
Velligan DI; Brain C; Bouérat Duvold L; Agid O
Front Psychiatry; 2019; 10():584. PubMed ID: 31551821
[No Abstract] [Full Text] [Related]
4. Increased schizophrenia family history burden and reduced premorbid IQ in treatment-resistant schizophrenia: a Swedish National Register and Genomic Study.
Kowalec K; Lu Y; Sariaslan A; Song J; Ploner A; Dalman C; Hultman CM; Larsson H; Lichtenstein P; Sullivan PF
Mol Psychiatry; 2021 Aug; 26(8):4487-4495. PubMed ID: 31712719
[TBL] [Abstract][Full Text] [Related]
5. Experiences, attitudes, and perceptions of caregivers of individuals with treatment-resistant schizophrenia: a qualitative study.
Brain C; Kymes S; DiBenedetti DB; Brevig T; Velligan DI
BMC Psychiatry; 2018 Aug; 18(1):253. PubMed ID: 30103719
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and predictors of treatment-resistant schizophrenia in a tertiary hospital in Northeast Brazil.
Soares DS; Carvalho DR; Ribeiro MDT; Diniz EJB; Rêgo AF
Trends Psychiatry Psychother; 2021 Jun; 43(4):270-7. PubMed ID: 34139114
[TBL] [Abstract][Full Text] [Related]
7. [Acute schizophrenia concept and definition: investigation of a French psychiatrist population].
Baylé FJ; Misdrahi D; Llorca PM; Lançon C; Olivier V; Quintin P; Azorin JM
Encephale; 2005; 31(1 Pt 1):10-7. PubMed ID: 15971635
[TBL] [Abstract][Full Text] [Related]
8. Point-in-time survey of healthcare resource utilization, employment, quality of life and caregiver status by disease severity in patients with schizophrenia in the US.
Kadakia A; Fan Q; Shepherd J; Bailey H; Dembek C; Walker C; Williams GR
Curr Med Res Opin; 2022 Mar; 38(3):469-478. PubMed ID: 34812100
[TBL] [Abstract][Full Text] [Related]
9. Predictors of Treatment-Resistant and Clozapine-Resistant Schizophrenia: A 12-Year Follow-up Study of First-Episode Schizophrenia-Spectrum Disorders.
Chan SKW; Chan HYV; Honer WG; Bastiampillai T; Suen YN; Yeung WS; Lam M; Lee WK; Ng RMK; Hui CLM; Chang WC; Lee EHM; Chen EYH
Schizophr Bull; 2021 Mar; 47(2):485-494. PubMed ID: 33043960
[TBL] [Abstract][Full Text] [Related]
10. Treatment resistant schizophrenia and neurological soft signs may converge on the same pathology: Evidence from explanatory analysis on clinical, psychopathological, and cognitive variables.
de Bartolomeis A; Prinzivalli E; Callovini G; D'Ambrosio L; Altavilla B; Avagliano C; Iasevoli F
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():356-366. PubMed ID: 28887181
[TBL] [Abstract][Full Text] [Related]
11. Identifying and characterizing treatment-resistant schizophrenia in observational database studies.
Jönsson L; Simonsen J; Brain C; Kymes S; Watson L
Int J Methods Psychiatr Res; 2019 Sep; 28(3):e1778. PubMed ID: 30957345
[TBL] [Abstract][Full Text] [Related]
12. Better adherence to guidelines among psychiatrists providing pharmacological therapy is associated with longer work hours in patients with schizophrenia.
Ito S; Ohi K; Yasuda Y; Fujimoto M; Yamamori H; Matsumoto J; Fukumoto K; Kodaka F; Hasegawa N; Ishimaru K; Miura K; Yasui-Furukori N; Hashimoto R
Schizophrenia (Heidelb); 2023 Nov; 9(1):78. PubMed ID: 37935686
[TBL] [Abstract][Full Text] [Related]
13. Treatment-resistant schizophrenia: Addressing white matter integrity, intracortical glutamate levels, clinical and cognitive profiles between early- and adult-onset patients.
Matrone M; Kotzalidis GD; Romano A; Bozzao A; Cuomo I; Valente F; Gabaglio C; Lombardozzi G; Trovini G; Amici E; Perrini F; De Persis S; Iasevoli F; De Filippis S; de Bartolomeis A
Prog Neuropsychopharmacol Biol Psychiatry; 2022 Mar; 114():110493. PubMed ID: 34883221
[TBL] [Abstract][Full Text] [Related]
14. Levels of glutamatergic neurometabolites in patients with severe treatment-resistant schizophrenia: a proton magnetic resonance spectroscopy study.
Tarumi R; Tsugawa S; Noda Y; Plitman E; Honda S; Matsushita K; Chavez S; Sawada K; Wada M; Matsui M; Fujii S; Miyazaki T; Chakravarty MM; Uchida H; Remington G; Graff-Guerrero A; Mimura M; Nakajima S
Neuropsychopharmacology; 2020 Mar; 45(4):632-640. PubMed ID: 31842203
[TBL] [Abstract][Full Text] [Related]
15. Modeling the effects of treatment resistance and anticholinergic burden on cognitive function domains in patients with schizophrenia.
Chan SKW; Pang TSW; Tsui HKH; Suen YN; Yan WC; Tsui CF; Poon LT; Chan CWH; Lo A; Cheung KM; Hui CLM; Chang WC; Lee EHM; Chen EYH; Honer WG
Psychiatry Res; 2024 Jul; 337():115985. PubMed ID: 38820652
[TBL] [Abstract][Full Text] [Related]
16. Attitudes of Italian Psychiatrists Toward the Evaluation of Physical Comorbidities and Sexual Dysfunction in Patients With Schizophrenia. Implications for Clinical Practice.
Monteleone P; Amore M; Cabassi A; Clerici M; Fagiolini A; Girardi P; Jannini EA; Maina G; Rossi A; Vita A; Siracusano A
Front Psychiatry; 2019; 10():842. PubMed ID: 31824349
[TBL] [Abstract][Full Text] [Related]
17. First-episode psychosis in treatment-resistant schizophrenia: a cross-sectional study of a long-term follow-up cohort.
Kanahara N; Yamanaka H; Suzuki T; Takase M; Iyo M
BMC Psychiatry; 2018 Sep; 18(1):274. PubMed ID: 30176881
[TBL] [Abstract][Full Text] [Related]
18. Differential cognitive performances between schizophrenic responders and non-responders to antipsychotics: correlation with course of the illness, psychopathology, attitude to the treatment and antipsychotics doses.
de Bartolomeis A; Balletta R; Giordano S; Buonaguro EF; Latte G; Iasevoli F
Psychiatry Res; 2013 Dec; 210(2):387-95. PubMed ID: 23910239
[TBL] [Abstract][Full Text] [Related]
19. Minor physical anomalies and craniofacial measures in patients with treatment-resistant schizophrenia.
Lin AS; Chang SS; Lin SH; Peng YC; Hwu HG; Chen WJ
Psychol Med; 2015 Jul; 45(9):1839-50. PubMed ID: 25515974
[TBL] [Abstract][Full Text] [Related]
20. The social and economic burden of treatment-resistant schizophrenia: a systematic literature review.
Kennedy JL; Altar CA; Taylor DL; Degtiar I; Hornberger JC
Int Clin Psychopharmacol; 2014 Mar; 29(2):63-76. PubMed ID: 23995856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
